Press What’s news at AbelsonTaylor Group
Select category
								
							Leveraging Multi-Touch Attribution for Greater Brand Marketing Success
Even in the present age of AI, big data and omnichannel marketing, pharma brands—for the most part—are stuck to the traditional idea that the last touch, the last communication someone receives before converting, should get all, or most of the credit for that conversion. Or, they might not even know which touchpoints to attribute credit.
In her article in Muse by Clio, Rebecca Visconti, VP of Marketing Intelligence, looks beyond that conventional worship of the last touch to provide evidence-based methods to calculate the real impact of every touchpoint more accurately.
Read the full article at Muse by Clio
Media Contact:
Recent Posts
What Pharma Can Teach Every Marketer About Risk, Regulation and Trust
What happens when regulation, trust, and creativity collide in healthcare marketing? In his latest guest post for the 4A’s and...
In the News Read more What Pharma Can Teach Every Marketer About Risk, Regulation and TrustElsa Varghese, M.D., Joins AbelsonTaylor Group as Medical Strategy Director
CHICAGO – October 16, 2025 — AbelsonTaylor Group, a leading independent healthcare marketing and communications agency, is pleased to announce...
Read Press Read more Elsa Varghese, M.D., Joins AbelsonTaylor Group as Medical Strategy DirectorThe case for independent agencies
As mergers continue to reshape the advertising industry, AbelsonTaylor Group President Jeff Berg shares his perspective with MM+M on the...
In the News Read more The case for independent agenciesConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.